Abstract:Programmed release of small molecular drugs from polymersomes is of great importance in drug delivery. A significant challenge is to adjust the membrane permeability in a well-controlled manner. Herein, we propose a strategy for controlling membrane phase separation by photo-cross-linking of the membrane-forming blocks with different molecular architectures. We synthesized three amphiphilic block copolymers with different membrane-forming blocks, which are poly(ethylene oxide) 43 - b -poly(( ε -caprolactone) 45 - stat -(( a -(cinnamoyloxymethyl)-1,2,3-triazol)caprolactone) 25 ) (PEO 43 - b -P(CL 45 - stat -CTCL 25 )), PEO 43 - b -P(CL 108 - stat -CTCL 16 ), and PEO 43 - b -PCTCL 4 - b -PCL 79 . These polymers were self-assembled into polymersomes using either a solvent-switch or powder rehydration method, and the obtained polymersomes were characterized by dynamic light scattering and transmission electron microscopy. Then the phase separation patterns within the polymersome membranes were investigated by mesoscopic dynamics (MesoDyn) simulations. To further confirm the change of the membrane permeability that resulted from the phase separation within the membrane, doxorubicin, as a small molecular drug, was loaded and released from the polymersomes. Due to the incompatibility between membrane-forming moieties (PCTCL and PCL), phase separation occurs and the release rate can be tuned by controlling the membrane phase pattern or by photo-cross-linking. Moreover, besides the compacting effect by formation of chemical bonds in the membrane, the cross-linking process can act as a driving force to facilitate the rearrangement and re-orientation of the phase pattern, which also influences the drug release behavior by modulating the cross-membrane distribution of the amorphous PCTCL moieties. In this way, the strategy of focusing on the membrane phase separation for the preparation of the polymersomes with finely tunable drug release rate can be envisioned and designed accordingly, which is of great significance in the field of delivery vehicles for programmed drug release.

Enzymatically Triggered Peptide-Lipid Conjugation of Designed Membrane Active Peptides for Controlled Liposomal Release

Influence of lipid vesicle properties on the function of conjugation dependent membrane active peptides

Sequence and length optimization of membrane active coiled coils for triggered liposome release

Tuning Liposome Membrane Permeability by Competitive Coiled Coil Heterodimerization and Heterodimer Exchange

De Novo Design of Selective Membrane‐Active Peptides by Enzymatic Control of Their Conformational Bias on the Cell Surface

Clickable,Oxidation-Responsive and Enzyme-Degradable Polypeptide:Synthesis,Characterization and Side Chain Modification

Controlled Release from Cleavable Polymerized Liposomes Upon Redox and Ph Stimulation

Modular and Automated Synthesis of Oligonucleotide-Small Molecule Conjugates for Cathepsin B Mediated Traceless Release of Payloads

Convergent in Situ Assembly of Injectable Lipogel for Enzymatically Controlled and Targeted Delivery of Hydrophilic Molecules

Enzyme-triggered Transition from Polymeric Vesicles to Core Cross-linked Micelles for Selective Release of Antimicrobial Agents

Releasable Conjugation of Polymers to Proteins

Protocol for protein modification using oxalyl thioester-mediated chemoselective ligation

Engineering a nanoscale liposome-in-liposome for in situ biochemical synthesis and multi-stage release

Synthesis of α,ω-bis-Mercaptoacyl Poly(alkyl oxide)s and Development of Thioether Cross-Linked Liposome Scaffolds for Sustained Release of Drugs

Therapeutic design of peptide modulators of protein-protein interactions in membranes

Controlling Membrane Phase Separation of Polymersomes for Programmed Drug Release

A Designed Lipopeptide with a Leucine Zipper As an Imbedded On/off Switch for Lipid Bilayers

In Situ Formation of a Biomimetic Lipid Membrane Triggered by an Aggregation-Enhanced Photoligation Chemistry

Enzymatic Cell-Surface Decoration with Proteins using Amphiphilic Lipid-Fused Peptide Substrates

Polymersome Membrane Engineering with Active Targeting or Controlled Permeability for Responsive Drug Delivery

Enzyme-modulate Conformational Changes in Amphiphile Peptide for Selectively Cell Delivery